Skip to content
Head to head

AxoGen vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: AXGN · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

AXGN +136.5%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
AXGNABT
Snapshot
SectorMedical DevicesMedical Devices
Last price55.75103.00
Change today-1.06%-0.84%
1-year return+117.2%-15.4%
Market cap$3.33B$178.39B
52-week range26.92 – 59.7280.89 – 126.70
Valuation
P/E (TTM)-88.4938.29
P/E percentile, own 5-yr range14th99th
P/B6.713.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.343.72
Net profit (TTM)$-20.31M$6.44B
Revenue (TTM)$266.93M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+26.2%+14.5%
Gross margin74.2%56.9%
Operating margin-5.2%13.8%
Net margin-12.0%9.7%
Free cash flow (TTM)$20.02M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership99.3%81.2%
Insider activity (12mo)29 buy / 18 sell36 buy / 12 sell
Short interest (% of float)11.7%1.1%
Analyst consensus100% buy (11)93% buy / 7% hold (15)
Analyst price target$58 (+4%)$122 (+18%)
StockVane view
StockVane Quant RatingC (98)D (22)
Company
Employees622115,000
Founded19771900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.